Stay updated on AV-101 for Levodopa Dyskinesia: PD Clinical Trial
Sign up to get notified when there's something new on the AV-101 for Levodopa Dyskinesia: PD Clinical Trial page.

Latest updates to the AV-101 for Levodopa Dyskinesia: PD Clinical Trial page
- Check4 days agoChange DetectedA sitewide NIH banner announces a terminology change from “Artificial Intelligence” to “Super Intelligence” and links to transition updates and FAQs.SummaryDifference1%

- Check11 days agoChange DetectedThe ClinicalTrials.gov footer revision number changed from v3.7.1 to v3.7.2 while the study record continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoChange DetectedThe footer revision marker was updated from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check32 days agoChange DetectedThe page now displays a 403 Forbidden error page, replacing the expected study content with a basic error screen. The 403 page indicates the study record is currently inaccessible on ClinicalTrials.gov.SummaryDifference17%

- Check39 days agoChange DetectedThe page shows an updated revision label, signaling a backend or UI update. The substantive study details remain unchanged.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page displays a new revision number, updating from v3.6.5 to v3.6.6, which signals a minor system or content-management update rather than a change to trial information.SummaryDifference0.1%

Stay in the know with updates to AV-101 for Levodopa Dyskinesia: PD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AV-101 for Levodopa Dyskinesia: PD Clinical Trial page.